Back to Trades
Kelly Michael Aaron
DirectorCIK 0001769668
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 4
- Active
- 2025–2026
Across 5 filings between 2025–2026, Kelly Michael Aaron, Director, has disclosed $5.1M in transactions — spread across 4 companies. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 8 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Award | $229.5K |
| Jun 3 | NEO NEOGENOMICS INC | Kelly Michael Aaron | Director | Exercise | $116.4K |
| May 14 | BOOM DMC Global Inc. | Kelly Michael Aaron | Director | Grant | $0 |
| Apr 27 | FOLD AMICUS THERAPEUTICS, INC. | Kelly Michael Aaron | Insider | Disposed | $3.1M |
| Aug 5 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Award | $1.7M |
5 filings